Xero FPO NZX, WiseTech Global Ltd or Aconex Ltd: Which is the best buy?

Is Aconex the cheapest of these 3 leading software companies?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Most investors are likely to be aware of Xero FPO NZX (ASX: XRO), Aconex Ltd (ASX: ACX) and WiseTech Global Ltd (ASX: WTC). The three are currently among the top 10 largest software companies trading on the ASX.

Despite operating in different industries (accounting, construction, and logistics), the three companies have a few things in common. Each employs a software as a service (SaaS) model and has growing subscription revenues and a global focus.

All three are highly innovative, founder-led, and were featured in the 2016 Tech Pioneers Report.

But how do they compare at current valuations?

The typical way to value SaaS companies is to look at revenues relative to market capitalisation or enterprise value. These need to be considered in the context of the company's growth rate and potential.

As with most other technology stocks on the ASX, shares in Xero and Aconex have experienced a pullback in recent months. WiseTech has been the exception, with shares still close to their all-time highs.

Xero

Xero has an enterprise value of $2.23 billion (NZD) and earned revenues of $251 million (NZD) over the last 12 months, giving an enterprise value/revenue ratio of 8.8. However, as I have previously written, annualised committed monthly revenue (ACMR) is a better metric as it provides a 12-month forward view based on current subscriber numbers (assuming no further growth). Xero today reported ACMR of $303 million (as at 30 September), giving a ratio of 7.35 relative to enterprise value.

In my view, this is a reasonable multiple to pay considering Xero's growth rate – ACMR grew by an impressive 53% in the last 12 months.

Aconex

For Aconex, an enterprise value of $864 million and trailing 12-month revenues of $123.36 million gives a ratio of around 7.

Aconex's revenues grew 50% on the prior year. A recent update included an estimate for 2017 revenues of up to $180 million, implying further growth of around 45% and a revenue multiple of 4.8. Revenues are expected to continue growing at 20%-25% for the next few years.

Shares have recently fallen nearly 40%. In my view, Aconex is starting to look like good value, however, shares are still more expensive than the revenue multiple of 3.5 paid by IPO investors in late 2014.

WiseTech Global

WiseTech has an enterprise value of $1.65 billion and revenues of $102.8 million, giving a ratio of around 16.

WiseTech's revenue grew 30% in the last year. Recently upgraded expectations for 2017 are for up to 50% in revenue growth to $148 million to $155 million implying a forward-looking revenue ratio of around 11.

WiseTech is a great business; as an investor, I am happy to hold, but in my view, new investors should wait for a pullback before investing. Considering their growth rates and revenue multiples, I prefer Aconex and Xero at current prices.

Motley Fool contributor Matthew Bugden has shares in WiseTech Global and Xero. The Motley Fool Australia owns shares of WiseTech Global and Xero. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »